Brief: Oncocyte Corp - Reduced Cash Burn To $3.6 Million In Q3

Insight Molecular Diagnostics

09/11/2023 12:35

Nov 9 (Reuters) - OncoCyte Corp  OCX.O :
    * ONCOCYTE CORP - REDUCED OUR CASH BURN TO $3.6 MILLION IN
Q3
    * ONCOCYTE CORP - GOING FORWARD, WE EXPECT TO MAINTAIN THIS
LOWER
LEVEL OF CASH BURN AND REMAIN BELOW $5 MILLION ON A QUARTERLY
BASIS
    * ONCOCYTE CORP - WE BELIEVE THAT ONCOCYTE IS WELL
POSITIONED FOR
GROWTH IN 2024 AND YEARS BEYOND
    * ONCOCYTE CORP - QTRLY LOSS PER SHARE $0.81
    * ONCOCYTE CORP - $14.2 MILLION IN CASH, CASH EQUIVALENTS,
AND
MARKETABLE SECURITIES AS OF SEPTEMBER 30, 2023

Source text for Eikon:  ID:nGNX4nG4mD 
Further company coverage:  OCX.O 

 ((Reuters.Briefs@thomsonreuters.com;))